StockNews.AI
TNDM
StockNews.AI
12 days

Tandem Diabetes Care Issues Voluntary Medical Device Correction for Select t:slim X2 Insulin Pumps

1. Tandem Diabetes Care issues a correction for potential t:slim X2 insulin pump errors. 2. Malfunction could lead to insulin delivery stoppage, impacting user health.

2m saved
Insight
Article

FAQ

Why Bearish?

The announcement of device correction may create concerns about product reliability, similar to past recalls causing stock declines.

How important is it?

The announcement of a medical device correction can significantly affect consumer trust and sales performance.

Why Short Term?

Immediate user concerns can impact sales and market perception in the upcoming quarter.

Related Companies

MDTABTBAX
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) has announced a voluntary medical device correction for select t:slim X2 insulin pumps to address a potential speaker-related issue that can trigger an error resulting in a discontinuation of insulin delivery. The error, which appears as a Malfunction 16 alarm to the user, will stop insulin delivery and terminate communication between the insulin pump and the continuous glucose monitoring (CGM) device. If not addressed, this.

Related News